Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127035991 | 12703599 | 1 | I | 20160824 | 20160831 | 20160831 | EXP | ES-JNJFOC-20160822901 | JANSSEN | SANTOS-GOMEZ M, LLORENS V, MESQUIDA M, BLANCO R, CALVO-RYO V, MAIZ O, ET AL. EFFICACY OF CERTOLIZUMAB IN PATIENTS WITH REFRACTORY UVEITIS TO OTHER BIOLOGIC THERAPY. STUDY OF 7 CASES. ARTHRITIS RHEUMATOL 2014;66:S548. | 0.00 | A | Y | 0.00000 | 20160831 | OT | ES | ES |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127035991 | 12703599 | 1 | SS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | UNKNOWN | 0 | LYOPHILIZED POWDER | ||||||||
127035991 | 12703599 | 2 | SS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | UNKNOWN | 0 | LYOPHILIZED POWDER | ||||||||
127035991 | 12703599 | 3 | SS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | UNKNOWN | 0 | LYOPHILIZED POWDER | ||||||||
127035991 | 12703599 | 4 | SS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | UNKNOWN | 0 | LYOPHILIZED POWDER | ||||||||
127035991 | 12703599 | 5 | SS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | UNKNOWN | 0 | LYOPHILIZED POWDER | ||||||||
127035991 | 12703599 | 6 | PS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | UNKNOWN | 103772 | LYOPHILIZED POWDER |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127035991 | 12703599 | 1 | Polychondritis |
127035991 | 12703599 | 2 | Crohn's disease |
127035991 | 12703599 | 3 | Psoriatic arthropathy |
127035991 | 12703599 | 4 | Ankylosing spondylitis |
127035991 | 12703599 | 5 | Retinal vasculitis |
127035991 | 12703599 | 6 | Behcet's syndrome |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127035991 | 12703599 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127035991 | 12703599 | Adverse event | |
127035991 | 12703599 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |